Study Stopped
Study cancelled
Resistance Training Intervention to Promote Lean Mass in Youth With IBD
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Evaluate feasibility, safety, and preliminary estimates of resistance training (RT) efficacy to promote lean body mass accrual in patients with CD aged 14-18. This will be achieved by conducting a parallel 2-arm randomized-controlled pilot trial of RT compared to usual care. At weeks 0 (pre-treatment), 6 (mid-treatment), and 12 (post- treatment), feedback regarding safety, feasibility, and acceptability will be collected from participants through surveys and interviews. Magnitude of the effect size of the intervention on LBM, muscle strength, and health-related quality of life (HRQoL) will also be estimated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2019
CompletedFirst Posted
Study publicly available on registry
July 12, 2019
CompletedStudy Start
First participant enrolled
March 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 6, 2020
CompletedJune 2, 2020
May 1, 2020
Same day
July 8, 2019
May 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in body composition as measured by DEXA
12 weeks
Change in muscle strength as measured using a hand dynamometer
12 weeks
Change in Health-related quality of life as measured by the PedsQL4.0
12 weeks
Secondary Outcomes (1)
Change in Disease Activity as measured by C-reactive protein blood test
12 weeks
Other Outcomes (1)
Total number of intervention sessions attended
12 weeks
Study Arms (2)
Usual Care (UC)
NO INTERVENTIONThose randomized to the UC group will complete baseline and post-intervention assessments only. No intervention will be administered.
Resistance Training Intervention (RT)
EXPERIMENTALThose randomized to the RT group will complete baseline and post-intervention assessments at weeks 0 and 12. For the intervention, they will complete resistance training for approximately 12 minutes 2x per week for 12 weeks.
Interventions
Static resistance training including two arm and two leg movements will be performed twice per week for 12 weeks.
Eligibility Criteria
You may qualify if:
- aged 14-18
- diagnosed with Crohn's Disease
- able to read, write, and speak English
- have a consenting caregiver who can commit to all study procedures
- have clearance from their primary treating IBD physician to enroll in the RT intervention
You may not qualify if:
- history of neuro-developmental or neuro-motor disorder (including but not limited to Intellectual Disability, Down Syndrome, or Cerebral Palsy)
- presence of another medical condition that prevents them from being able to participate in physical activity
- currently participating in a formal exercise or physical activity program beyond physical education offered at school
- currently on systemic steroids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 8, 2019
First Posted
July 12, 2019
Study Start
March 6, 2020
Primary Completion
March 6, 2020
Study Completion
March 6, 2020
Last Updated
June 2, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share